Concepedia

Martijn van Essen

MV

25

Publications

3K

Citations

22

H-Index

2006

Active since

Affiliations

Erasmus MC(Current)

Erasmus University Rotterdam

DNV (Netherlands)

University of Gothenburg

Sahlgrenska University Hospital

Martijn van Essen is an author at Erasmus MC specializing in engineering, chemical engineering, and chemistry.

ORCID

Top concepts

Publications per year

2006–2025

25

Publications

25

Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival

Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam et al. · Journal of Clinical Oncology · 2008 · 1.4K citations · Full text

Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]Octreotate

Saima Khan, Eric P. Krenning, Martijn van Essen et al. · Journal of Nuclear Medicine · 2011 · 177 citations · Full text

Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma.

Martijn van Essen, Eric P. Krenning, P.P.M. Kooij et al. · PubMed · 2006 · 161 citations

Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin

Martijn van Essen, Eric P. Krenning, Willem H. Bakker et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 133 citations

, , +10

Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours

Martijn van Essen, Eric P. Krenning, Boen L.R. Kam et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 131 citations · Full text

Rows per page

1–5 of 25